Accuray Inc (ARAY) · Oct 13, 2026 · Exec change

Accuray director to leave board, with no company dispute cited

Director departure — Will not stand for re-election at the November 2026 annual meeting

Accuray disclosed a director’s planned departure after its November 2026 annual meeting, while saying the decision is unrelated to company operations or policy.

Accuray is a radiation-therapy equipment maker executing a broader 2026 transformation involving financial strengthening, strategic partnerships, technology rollouts and operational changes.

This is a governance change, not a business reset. Mika Nishimura will not seek re-election at the November 2026 annual meeting and will remain a director and Compensation Committee chair until then. 〔0〕

The filing removes the obvious negative interpretation. Accuray explicitly says her decision is not tied to disagreement with the company, the board, or its operations, policies or practices. 〔1〕 There is no disclosed change to strategy, financial outlook, management execution or capital structure, so the filing carries little direct information about Accuray’s operating turnaround.

Bottom line: This is a modest board-refresh disclosure rather than a signal that Accuray’s business plan has changed. Its significance is limited unless the company later identifies a replacement or links the transition to broader governance changes.

What to watch next

2026 annual meeting, November 2026

Original filing on SEC EDGAR

More Accuray Inc news

Accuray director to leave board, with no company dispute cited | ARAY Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.